← 返回事件
持续讨论商业

Novo Nordisk is seeking Chinese approval for its oral weight loss pill

图:Quartz

发生了什么

China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market

摘要按规则整理自下方来源原文

来源